(Q37247725)

19 August 2017

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis (English)

1 reference

19 August 2017

0 references

1 reference

Boris V Nikonenko

1

1 reference

19 August 2017

Venkata M Reddy

2

1 reference

19 August 2017

Marina Protopopova

3

1 reference

19 August 2017

Elena Bogatcheva

4

1 reference

19 August 2017

Leo Einck

5

1 reference

19 August 2017

Carol A Nacy

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

4 May 2009

1 reference

Antimicrobial Agents and Chemotherapy

19 August 2017

1 reference

19 August 2017

53

1 reference

19 August 2017

7

1 reference

19 August 2017

3138-3139

1 reference

In vitro antimycobacterial activities of capuramycin analogues

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704676

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

3 September 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.1047

Identifiers

DOI

10.1128/AAC.00366-09

1 reference

release_wu44xt6y3bbcnexqdyalbrluyq

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wu44xt6y3bbcnexqdyalbrluyq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 August 2017

PubMed publication ID

19414567

1 reference